Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease
- 6 June 2006
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 21 (6), 880-881
- https://doi.org/10.1002/mds.20814
Abstract
Mutations in the leucine‐rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD). We report here the frequency of a common heterozygous mutation, 2877510G>A, which produces a glycine‐to‐serine amino acid substitution at codon 2019 in idiopathic Taiwanese PD. The extreme rarity of the G2019S mutation in our population suggests the occurrence of this mutation resulted from a common European founder. © 2006 Movement Disorder SocietyKeywords
This publication has 6 references indexed in Scilit:
- Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European PopulationsAmerican Journal of Human Genetics, 2005
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic PathologyNeuron, 2004
- Prevalence, incidence, and mortality of PDNeurology, 2001
- Worldwide Occurrence of Parkinson's Disease: An Updated ReviewNeuroepidemiology, 1993
- Criteria for diagnosing Parkinson's diseaseAnnals of Neurology, 1992